Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Tri-Staple 2.0 Reinforced Reload

K-Number: K173270 · 2018-02-20

ApplicantCovidien
Decision Date2018-02-20
Product CodeGDW
Advisory CommitteeSU
DecisionSubstantially Equivalent

Device Summary

Tri-Staple 2.0 Reinforced Reload is a medical device manufactured by Covidien. It received FDA 510(k) clearance on 2018-02-20 under approval number K173270. The device is classified under product code GDW. It was reviewed by the SU advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Tri-Staple 2.0 Reinforced Reload?

Tri-Staple 2.0 Reinforced Reload is a medical device that received FDA 510(k) clearance on 2018-02-20. It is manufactured by Covidien. The 510(k) number is K173270.

When was Tri-Staple 2.0 Reinforced Reload approved by the FDA?

Tri-Staple 2.0 Reinforced Reload received FDA 510(k) clearance on 2018-02-20, under approval number K173270.

What company makes Tri-Staple 2.0 Reinforced Reload?

Tri-Staple 2.0 Reinforced Reload is manufactured by Covidien.

What is the FDA product code for Tri-Staple 2.0 Reinforced Reload?

The FDA product code for Tri-Staple 2.0 Reinforced Reload is GDW.

Other Devices by Covidien

View all 61 devices →

Related Devices (Code: GDW)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.